ClinicalTrials.govpublic full text
Assessment of CFTR-Modulator Treatment in Cystic Fibrosis Lung Disease Using Novel Structural and Functional MRI
group 1: healthy controls, group 2: stable cf, group 3: cf participants anticipated to receive cftr-modulator therapy, group 4: 4-8 yo cf participants starting triple combination modulator therapy, cftr modulator treatment, xenon mri, lung, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 891327
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.